Search

ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Indexing Info About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

SCImago Journal & Country Rank

2024, Vol 14, No. 4

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of various integrative fields with Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Publication Advantages in Advanced Pharmaceutical Bulletin are:

Free of charge publication for all types of articles
Fast and constructive peer review
Easy and quick online submission of manuscripts
Author friendly review
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Research Article

1. Evaluation of NPP1 as a Novel Biomarker of Coronary Artery Disease: A Pilot Study in Human Beings

Amir Hooshang Mohammadpour , Saeed Nazemi, Fatemeh Mashhadi, Atefeh Rezapour, Mohammad Afshar, Sepideh Afzalnia, Afsaneh Mohammadi, Hamid Reza Mashreghi Moghadam, Maryam Moradian, Seyed Mohammad Hasan Moallem, Saeed Falahaty, Azadeh Zayerzadeh, Sepideh Elyasi*

Adv Pharm Bull. 2018;8(3): 489-493. doi: 10.15171/apb.2018.057

PMCID: PMC6156488 PMID: 30276146 Scopus ID: 85052559472

Article

PDF

XML

Cited By:

2

0

3

Review Article

2. Micromanaging Glucose Tolerance and Diabetes

Negar Saliani, Soheila Montazersaheb, Shideh Montasser Kouhsari*

Adv Pharm Bull. 2017;7(4): 547-556. doi: 10.15171/apb.2017.066

PMCID: PMC5788209 PMID: 29399544 Scopus ID: 85043384245

Article

PDF

XML

Cited By:

11

6

13

Review Article

3. Nanotechnology Approaches for Enhanced CNS Drug Delivery in the Management of Schizophrenia

Rajalakshmi Rajendran , Krishnakumar Neelakandha Menon*, Sreeja Chandrasekharan Nair*

Adv Pharm Bull. 2022;12(3): 490-508. doi: 10.34172/apb.2022.052

PMCID: PMC9348538 PMID: 35935056 Scopus ID: 85140416915

Article

PDF

Full Text

XML

Cited By:

0

0

7

Short Communication

4. Differential Expression of Serum Exosomal miRNAs in Breast CancerPatients and Healthy Controls

Rahim Asgari , Jafar Rezaie*

Adv Pharm Bull. 2022;12(4): 858-862. doi: 10.34172/apb.2022.088

PMCID: PMC9675933 PMID: 36415626 Scopus ID: 85140415349

Article

PDF

Full Text

XML

Cited By:

0

3

1

Mini Review

5. Tumor-Specific Growth Factor (TSGF): A Futuristic Tumor Biomarker in Early Diagnosis of Cancer

Bhagyalakshmi Nair , Anisha Kuriakose , Bilha Baby, Lekshmi.R. Nath*

Adv Pharm Bull. 2023;13(3): 483-488. doi: 10.34172/apb.2023.051

PMCID: PMC10460812 PMID: 37646066

Article

PDF

Full Text

XML

Cited By:

0

3

Review Article

6. Challenges of Serum Creatinine Level in GFR Assessment and Drug Dosing Decisions in Kidney Injury

Xinyi Wang , Jing Mu, Kexin Ma, Yanrong Ma*

Adv Pharm Bull. 2024;14(4): 745-758. doi: 10.34172/apb.42345

Article

PDF

Suppl 1

XML

Cited By: